Brandywine Global Investment Management LLC Raises Stake in Cigna Group $CI

Brandywine Global Investment Management LLC increased its position in Cigna Group (NYSE:CI) by 60.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 301,723 shares of the health services provider’s stock after buying an additional 113,805 shares during the period. Brandywine Global Investment Management LLC’s holdings in Cigna Group were worth $83,043,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Beacon Financial Strategies CORP purchased a new stake in Cigna Group in the 4th quarter worth approximately $28,000. Lodestone Wealth Management LLC purchased a new position in shares of Cigna Group during the 4th quarter worth $32,000. Collier Financial purchased a new position in shares of Cigna Group during the 3rd quarter worth $34,000. Creative Financial Designs Inc. ADV boosted its holdings in shares of Cigna Group by 147.3% during the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock worth $37,000 after purchasing an additional 81 shares during the last quarter. Finally, Activest Wealth Management grew its position in shares of Cigna Group by 1,050.0% in the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 126 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of NYSE CI opened at $290.17 on Monday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. Cigna Group has a 1-year low of $239.51 and a 1-year high of $338.89. The company has a market capitalization of $76.76 billion, a price-to-earnings ratio of 12.30, a PEG ratio of 1.12 and a beta of 0.28. The business has a 50-day moving average of $279.58 and a 200-day moving average of $277.29.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The firm had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities analysts anticipate that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. The trade was a 85.46% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research firms recently commented on CI. Guggenheim upped their target price on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Raymond James Financial set a $340.00 price target on Cigna Group in a report on Friday, May 1st. The Goldman Sachs Group increased their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Sanford C. Bernstein boosted their target price on shares of Cigna Group from $358.00 to $371.00 and gave the company an “outperform” rating in a report on Tuesday, May 5th. Finally, Morgan Stanley upped their price target on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $338.30.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.